Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus cisplatin versus placebo plus cisplatin for malignant pleural or peritoneal effusion
CTR20210869Phase 3Active
- Sponsor
- Simcere
- Start
- Jul 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of endostar, cisplatin in malignant pleural effusion (MPE), malignant ascites, sponsored by Simcere. Started Jul 2021; status: active.
02
Drugs
endostarcisplatin
03
Conditions
malignant pleural effusion (MPE)malignant ascites
Beyond the preview
Go deeper on CTR20210869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210869.